PLUS THERAPEUTICS, Inc.PLUS THERAPEUTICS, Inc.PLUS THERAPEUTICS, Inc.

PLUS THERAPEUTICS, Inc.

No trades
See on Supercharts

PSTV fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
PSTV has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company